DexCom, Inc. Stock price

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-03-01 EST 5-day change 1st Jan Change
121.7 USD +5.80% Intraday chart for DexCom, Inc. +4.71% -1.89%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 4.33B 5.86B Sales 2025 * 5.15B 6.98B Capitalization 46.93B 63.63B
Net income 2024 * 673M 912M Net income 2025 * 882M 1.2B EV / Sales 2024 * 11.2 x
Net Debt 2024 * 1.51B 2.05B Net Debt 2025 * 980M 1.33B EV / Sales 2025 * 9.31 x
P/E ratio 2024 *
73.1 x
P/E ratio 2025 *
56.8 x
Employees 9,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.80%
1 week+4.71%
Current month+5.80%
1 month-0.70%
3 months+4.39%
6 months+19.48%
Current year-1.89%
More quotes
1 week
113.05
Extreme 113.05
122.23
1 month
113.05
Extreme 113.05
127.37
Current year
113.05
Extreme 113.05
132.03
1 year
74.75
Extreme 74.75
139.55
3 years
66.89
Extreme 66.8925
164.86
5 years
26.86
Extreme 26.86
164.86
10 years
7.02
Extreme 7.0225
164.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 07-10-31
Director of Finance/CFO 44 18-08-31
Chief Tech/Sci/R&D Officer 47 22-09-30
Members of the board TitleAgeSince
Director/Board Member 65 09-11-19
Director/Board Member 63 14-11-18
Director/Board Member 69 09-07-08
More insiders
Date Price Change Volume
24-03-01 121.7 +5.80% 4,530,497
24-02-29 115.1 +0.74% 3,557,097
24-02-28 114.2 -0.95% 2,764,224
24-02-27 115.3 -0.73% 2,269,287
24-02-26 116.2 -0.08% 2,812,732

Delayed Quote Nasdaq, March 01, 2024 at 04:00 pm

More quotes
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 73.6% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
121.7 USD
Average target price
146.4 USD
Spread / Average Target
+20.25%
Consensus
  1. Stock
  2. Equities
  3. Stock DexCom, Inc. - Nasdaq
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW